Secondary hyperparathyroidism is associated with higher mortality in men with moderate to severe chronic kidney disease  C.P. Kovesdy, S. Ahmadzadeh,

Slides:



Advertisements
Similar presentations
Volume 82, Issue 12, Pages (December 2012)
Advertisements

Urine Potassium Excretion, Kidney Failure, and Mortality in CKD
Vitamin D levels and patient outcome in chronic kidney disease
Optimization of pre-ESRD care: The key to improved dialysis outcomes
FIGURE 1 Flow chart of the study population
Chronic Kidney Disease in Diabetes
Volume 67, Pages S1-S7 (June 2005)
Thyroid Status and Death Risk in US Veterans With Chronic Kidney Disease  Connie M. Rhee, MD, MSc, Kamyar Kalantar-Zadeh, MD, MPH, PhD, Vanessa Ravel,
Mitchell H. Rosner, W. Kline Bolton  Kidney International 
Volume 83, Issue 3, Pages (March 2013)
Volume 58, Issue 1, Pages (July 2000)
Anemia treatment in chronic kidney disease accompanied by diabetes mellitus or congestive heart failure  Steven Fishbane, Nobuyuki Miyawaki  Kidney International 
Volume 93, Issue 4, Pages (April 2018)
FGF23 or PTH: which comes first in CKD ?
Volume 79, Issue 2, Pages (January 2011)
Association of Relatively Low Serum Parathyroid Hormone With Malnutrition- Inflammation Complex and Survival in Maintenance Hemodialysis Patients  Ramanath.
Volume 79, Issue 12, Pages (June 2011)
Survival differences between peritoneal dialysis and hemodialysis among “large” ESRD patients in the United States  Austin G. Stack, Bhamidipati V.R.
Calcium balance in normal individuals and in patients with chronic kidney disease on low- and high-calcium diets  David M. Spiegel, Kate Brady  Kidney.
Reassessment of the care of the patient with chronic kidney disease
John P. Middleton, Patrick H. Pun  Kidney International 
Volume 82, Issue 12, Pages (December 2012)
Chapter 3: Management of progression and complications of CKD
Volume 86, Issue 4, Pages (October 2014)
Volume 88, Issue 2, Pages (August 2015)
Audit-based education: a potentially effective program for improving guideline achievement in CKD patients  Moniek C.M. de Goeij, Joris I. Rotmans  Kidney.
Glycemic Status and Mortality in Chronic Kidney Disease According to Transition Versus Nontransition to Dialysis  Connie M. Rhee, MD, MSc, Csaba P. Kovesdy,
Volume 79, Pages S9-S13 (April 2011)
Volume 76, Pages S50-S99 (August 2009)
Volume 79, Issue 12, Pages (June 2011)
Steven G. Coca, Swathi Singanamala, Chirag R. Parikh 
Volume 68, Issue 6, Pages (December 2005)
C.Y. Hsu, J.D. Ordoñez, G.M. Chertow, D. Fan, C.E. McCulloch, A.S. Go 
Volume 84, Issue 5, Pages (November 2013)
Comorbidity and confounding in end-stage renal disease
Volume 86, Issue 4, Pages (October 2014)
Survival advantage in Asian American end-stage renal disease patients1
Use of vitamin D in chronic kidney disease patients
Jennifer E. Flythe, Stephen E. Kimmel, Steven M. Brunelli 
Correction to "Prevalence of abnormal serum vitamin D, PTH, calcium, and phosphorus in patients with chronic kidney disease: results of the study to evaluate.
U-shaped effect of eGFR and mortality
The calcium–phosphorus in guidelines for CKD-MBD
Volume 70, Issue 12, Pages (December 2006)
Volume 86, Issue 3, Pages (September 2014)
Volume 73, Issue 12, Pages (June 2008)
Volume 74, Pages S88-S93 (December 2008)
Volume 58, Issue 1, Pages (July 2000)
Vitamin D levels and patient outcome in chronic kidney disease
Methods for guideline development
Volume 76, Issue 1, Pages (July 2009)
Volume 76, Issue 9, Pages (November 2009)
Volume 73, Issue 8, Pages (April 2008)
Arjang Djamali, Christina Kendziorski, Peter C. Brazy, Bryan N. Becker 
Volume 80, Issue 12, Pages (December 2011)
Volume 77, Issue 12, Pages (June 2010)
Volume 82, Issue 3, Pages (August 2012)
Volume 81, Issue 7, Pages (April 2012)
Volume 56, Issue 3, Pages (September 1999)
Volume 73, Issue 5, Pages (March 2008)
K. Kalantar-Zadeh, J. D. Kopple, N. Kamranpour, A. M. Fogelman, M
Volume 80, Issue 10, Pages (November 2011)
Volume 75, Issue 1, Pages (January 2009)
Areef Ishani, Allan J. Collins, Charles A. Herzog, Robert N. Foley 
Recent developments in the management of secondary hyperparathyroidism
Vitamin D deficiency and anemia in early chronic kidney disease
Thiazolidinedione use is associated with better survival in hemodialysis patients with non-insulin dependent diabetes  Steven M. Brunelli, Ravi Thadhani,
Friends, social networks, and progressive chronic kidney disease
Optimization of pre-ESRD care: The key to improved dialysis outcomes
Among three residual kidney function (RKF) indices, only residual urine volume (UV) indicated an independent prognostic value in patients with UV≥0.1 or.
Association between hyperphosphatemia (serum phosphorus ≥4
Presentation transcript:

Secondary hyperparathyroidism is associated with higher mortality in men with moderate to severe chronic kidney disease  C.P. Kovesdy, S. Ahmadzadeh, J.E. Anderson, K. Kalantar-Zadeh  Kidney International  Volume 73, Issue 11, Pages 1296-1302 (June 2008) DOI: 10.1038/ki.2008.64 Copyright © 2008 International Society of Nephrology Terms and Conditions

Figure 1 Estimated log relative hazards of all-cause mortality for continuous PTH in a multivariable regression spline model adjusted for age, race, BMI, smoking status, Charlson comorbidity index, diabetes mellitus, use of activated vitamin D and calcium-containing medications, estimated GFR, and serum levels of calcium, phosphorus, albumin and cholesterol. Dashed lines, 95% pointwise CIs. Kidney International 2008 73, 1296-1302DOI: (10.1038/ki.2008.64) Copyright © 2008 International Society of Nephrology Terms and Conditions

Figure 2 Multivariable adjusted hazard ratios (95% CIs) of all-cause mortality associated with an intact PTH level >65 pg ml−1 compared to <65 pg ml−1, overall and in selected subgroups. Models were adjusted for age, race, BMI, smoking status, Charlson comorbidity index, diabetes mellitus, use of activated vitamin D and calcium-containing medications, estimated GFR, and serum levels of calcium, phosphorus, albumin and cholesterol. Kidney International 2008 73, 1296-1302DOI: (10.1038/ki.2008.64) Copyright © 2008 International Society of Nephrology Terms and Conditions

Figure 3 Estimated log relative hazards of all-cause mortality for continuous PTH in a multivariable regression spline model in subgroups of patients with CKD stage 3 and stages 4–5, adjusted for age, race, BMI, smoking status, Charlson comorbidity index, diabetes mellitus, use of activated vitamin D and calcium-containing medications, estimated GFR, and serum levels of calcium, phosphorus, albumin and cholesterol. Dashed lines, 95% pointwise CIs. Kidney International 2008 73, 1296-1302DOI: (10.1038/ki.2008.64) Copyright © 2008 International Society of Nephrology Terms and Conditions

Figure 4 Estimated log relative hazards of the composite outcome of predialysis all-cause mortality and end-stage renal disease for continuous PTH in a multivariable regression spline model, adjusted for age, race, BMI, smoking status, Charlson comorbidity index, diabetes mellitus, estimated GFR, serum levels of calcium, phosphorus, albumin and cholesterol, proteinuria, and the use of activated vitamin D, angiotensin-converting enzyme inhibitors, statins and calcium-containing medications. Dashed lines, 95% pointwise CIs. Kidney International 2008 73, 1296-1302DOI: (10.1038/ki.2008.64) Copyright © 2008 International Society of Nephrology Terms and Conditions